Market Update
HealthTech M&A Transactions (US,EU) 2022 – Q3 2026
• Capability-Driven Consolidation: Buyers prioritize workflow, data and distribution capabilities over scale alone, targeting imaging, RCM, interoperability and payer technology.
• AI With Measurable Returns: Buyers target billing, denial management and clinical documentation automation, favoring proven adoption and financial returns.
• Platform Expansion Through Add-ons: Strategic and PE-backed buyers acquire complementary software to broaden platforms and meet demand for fewer technology vendors.
• Revenue Quality and Integration: Recurring revenue, profitability and retention drive selection, while interoperability, cybersecurity and implementation costs shape diligence.
US HCIT Venture Funding 2022 – 3Q 2026
• Selective Funding Recovery: Capital availability is improving, but fundraising remains uneven as investors favor companies with established adoption and commercial momentum.
• Mega-Rounds Drive Funding: $100M+ rounds captured 45% of U.S. digital-health funding in H1 2026, concentrating capital rather than signaling a broad-based recovery.
• AI Alone Is Not Enough: Investors increasingly prioritize workflow integration, healthcare expertise and measurable returns over standalone AI capabilities.
• Commercial Proof Drives Selection: Revenue traction, validated outcomes and credible scaling plans carry greater weight than growth projections or pilot deployments alone.
Strategic M&As by Sector
EHR & Health IT
RCM
Pharma IT
Digital Health
Macro Themes
AI-Native EHR & Clinical Workflows: EHRs are becoming AI-enabled workflow platforms, embedding documentation, decision support, automation and agentic tools into care delivery.
Interoperability & Connected Data: FHIR, APIs and cloud infrastructure are improving data exchange across EHRs, providers, payers and third-party applications.
RCM & Administrative Automation: Rising denials and administrative costs are accelerating AI adoption across billing, prior authorization, payment integrity and claims automation.
Shift Toward Value-Based Care: Outcome-based reimbursement is increasing demand for technologies that improve care quality, lower costs and demonstrate ROI.
Healthcare Workforce Efficiency: Clinician shortages and administrative burden are driving automation across documentation, credentialing, scheduling and onboarding.
Clinical AI & Imaging Transformation: AI is shifting from standalone algorithms toward integrated diagnostic and clinical workflow platforms, particularly in medical imaging.
Regulatory & Reimbursement Modernization: Evolving digital-health frameworks are creating clearer regulatory and reimbursement pathways for software-based healthcare technologies.
Platform Consolidation: Health systems are favoring integrated platforms over point solutions, driving vendor rationalization and strategic M&A.
ROI-Driven Technology Spending: HCIT investment is increasingly tied to measurable productivity, cost savings, reimbursement capture and margin improvement.
Cybersecurity & Infrastructure Resilience: Rising cyber threats are increasing investment in secure cloud infrastructure, data protection and business continuity.
Notable HCIT Transactions – Past 12 Months
HCIT Transactions - October 2026
Public Market Overview – Last 12 Months
Index Performance Market Cap Value (%)
EV/ LTM EBITDA
EV / LTM Revenue
Commentary
Index Performance: Benefits/Telehealth (+11.4%) led the sector, reflecting stronger performance among selected digital-care platforms, while Pharma Services (−4.5%) lagged despite improving CRO demand indicators.
EV / LTM EBITDA: Multiples compressed across major HCIT segments as investors focused on sustainable earnings. Benefits/Telehealth (32x) and VBC (25x) remain elevated relative to EHR/RCM (14x), partly reflecting differences in earnings margins and business models.
EV / LTM Revenue: EHR/RCM commands the highest valuation at 7.2x, reflecting recurring software revenue and automation demand. VBC remains lowest at 0.6x amid medical-cost exposure, while Pharma Services trades at 4.8x.
HealthTech Public Market Valuation Snapshot
HCIT Earnings Updates
